Skeletal muscle is a major organ of insulin-induced glucose metabolism. In addition, loss of
muscle mass is closely linked to insulin resistance (IR) and metabolic syndrome (Met-S) …

Although there are several reviews that report the interrelationship between sarcopenia and
obesity and insulin resistance, the relation between sarcopenia and the other signs that …

The incidence and prevalence of metabolic and musculoskeletal diseases are increasing.
Type 2 diabetes mellitus (T2DM) is characterized by insulin resistance, inflammation …

Skeletal muscle is the most abundant body tissue accounting for many physiological
functions. However, muscle mass and functions are not routinely assessed. Sarcopenia is …

The associations between sarcopenia and metabolic syndrome (MetS) in non-obese middle-
aged and older adults remain controversial. Thus, this meta-analysis aimed to evaluate the …

Sarcopenia, defined as the loss of skeletal muscle mass and strength and/or a decrease in
physical performance, is classically related to aging. However, chronic disease, including …

Aims Metabolic syndrome (MetS) increases the risk of diabetes mellitus (DM),
cardiovascular disease (CVD), cancer, and mortality. Sarcopenia has been reported as a …

Recent epidemiological evidence suggests that effects of cardiovascular risk factors may
vary depending on sex and age. In this study, we assessed the associations of metabolic …

At the present time, there is only limited understanding of the public health significance of
sarcopenia. The well-recognized functional consequences of sarcopenia include gait and …

Diabetes and sarcopenia are emerging as serious public health issues. Sarcopenia, an age-
related disorder characterized by loss of skeletal muscle mass and function, is recognized …